Skip Navigation



Carcinogenesis Advance Access published online on September 30, 2004

Carcinogenesis, doi:10.1093/carcin/bgh292
© 2004 by Oxford University Press
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow Supplementary Data
Right arrow All Versions of this Article:
26/1/229    most recent
bgh292v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Tanaka, T.
Right arrow Articles by Wakabayashi, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tanaka, T.
Right arrow Articles by Wakabayashi, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Received July 21, 2004
Revised September 15, 2004
Accepted September 17, 2004

CARCINOGENESIS

Colonic adenocarcinomas rapidly induced by the combined treatment with 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and dextran sodium sulfate in male ICR mice possess {beta}-catenin gene mutations and increases immunoreactivity for {beta}-catenin, cyclooxygenase-2, and inducible nitric oxide synthase

Takuji Tanaka 1, Rikako Suzuki 2, Hiroyuki Kohno 1, Shigeyuki Sugie 1, Mami Takahashi 3, and Keiji Wakabayashi 3

1 The Oncologic Pathology, Kanazawa Medical University, 1-1 Daigaku, Uchinada, Ishikawa 920-0293
2 The Oncologic Pathology, Kanazawa Medical University, 1-1 Daigaku, Uchinada, Ishikawa 920-0293; Resarch Fellow of the Japan Science for the Promotion of Science, National Cancer Research Institute, 5-1-1 Tsukiji, Chuoku, Tokyo 104-0045, Japan
3 Cancer Prevention Basic Research Project, National Cancer Research Institute, 5-1-1 Tsukiji, Chuoku, Tokyo 104-0045, Japan


   Abstract

Heterocyclic amines are known to be important environmental carcinogens in several organs including colon. Because a lack of sufficient animal models using these for colon carcinogenesis, the aim of this study was to induce colonic epithelial malignancies within a short-term period and analyze the expression of cycooxygenase-2, inducible nitric oxide synthase and {beta}-catenin, and mutation of {beta}-catenin gene in induced tumors. Male ICR mice were given a single intragastric administration (200 mg/kg body weight) of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine or 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline, and followed by 2% dextran sodium sulfate in drinking water for a week. The expression of {beta}-catenin, cyclooxygenase-2 and inducible nitric oxide synthase was immunohistochemically assessed in colonic epithelial lesions and the {beta}-catenin gene mutations in colonic adenocarcinomas induced were analyzed by the single strand conformation polymorphism method, restriction enzyme fragment length polymorphism and direct sequencing. At week 16, a high incidence of colonic neoplasms with dysplastic lesions developed in mice received 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and dextran sodium sulfate, but a few in those given 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline and dextran sodium sulfate Immunohistochemically, the adenocarcinomas induced were all positive for three proteins. All 7 adenocarcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and dextran sodium sulfate have mutations. The findings suggest that dextran sodium sulfate exerts a powerful tumor-promoting effects on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-initiated colon carcinogenesis in mice and this mouse model is useful for investigating environment-related colon carcinogenesis within a short-term period.

Keywords: Heterocyclic amines; DSS; Colonic neoplasms; Mice; {beta}-Catenin.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CarcinogenesisHome page
D. W. Rosenberg, C. Giardina, and T. Tanaka
Mouse models for the study of colon carcinogenesis
Carcinogenesis, February 1, 2009; 30(2): 183 - 196.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
W.-C. L. Chang, R. A. Coudry, M. L. Clapper, X. Zhang, K.-L. Williams, C. S. Spittle, T. Li, and H. S. Cooper
Loss of p53 enhances the induction of colitis-associated neoplasia by dextran sulfate sodium
Carcinogenesis, November 1, 2007; 28(11): 2375 - 2381.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
T. Imai, K. Fukuta, M. Hasumura, Y.-M. Cho, Y. Ota, S. Takami, H. Nakagama, and M. Hirose
Significance of inflammation-associated regenerative mucosa characterized by Paneth cell metaplasia and {beta}-catenin accumulation for the onset of colorectal carcinogenesis in rats initiated with 1,2-dimethylhydrazine
Carcinogenesis, October 1, 2007; 28(10): 2199 - 2206.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
R. Suzuki, H. Kohno, S. Sugie, H. Nakagama, and T. Tanaka
Strain differences in the susceptibility to azoxymethane and dextran sodium sulfate-induced colon carcinogenesis in mice
Carcinogenesis, January 1, 2006; 27(1): 162 - 169.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
A. Nishikawa, T. Imazawa, Y. Kuroiwa, Y. Kitamura, K. Kanki, Y. Ishii, T. Umemura, and M. Hirose
Induction of Colon Tumors in C57BL/6J Mice Fed MeIQx, IQ, or PhIP Followed by Dextran Sulfate Sodium Treatment
Toxicol. Sci., April 1, 2005; 84(2): 243 - 248.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.